Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,750 | -2,723 | -8,368 | -6,273 | -4,255 |
| Depreciation Amortization | 114 | 58 | 224 | 193 | 110 |
| Other Working Capital | 321 | 241 | -457 | -387 | -620 |
| Other Operating Activity | 318 | 105 | 787 | 608 | 546 |
| Operating Cash Flow | $-5,997 | $-2,319 | $-7,814 | $-5,859 | $-4,219 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -5,036 | N/A | N/A |
| PPE Investments | -4 | -4 | -44 | -41 | -38 |
| Purchase Of Investment | -4,575 | -3,723 | -13,354 | -11,445 | -11,445 |
| Sale Of Investment | 5,699 | 1,376 | 14,541 | 8,234 | 6,316 |
| Other Investing Activity | -98 | -1 | 3 | 4 | 5 |
| Investing Cash Flow | $1,022 | $-2,352 | $-3,891 | $-3,248 | $-5,163 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1 | 1 | 10,050 | 10,000 | 10,000 |
| Other Financing Activity | -28 | -28 | 6,949 | -91 | -91 |
| Financing Cash Flow | $-26 | $-26 | $16,999 | $9,909 | $9,909 |
| Beginning Cash Position | 6,089 | 6,089 | 794 | 794 | 794 |
| End Cash Position | 1,086 | 1,391 | 6,089 | 1,597 | 1,322 |
| Net Cash Flow | $-5,002 | $-4,697 | $5,294 | $802 | $527 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,997 | -2,319 | -7,814 | -5,859 | -4,219 |
| Capital Expenditure | -4 | -4 | -44 | -41 | -38 |
| Free Cash Flow | -6,002 | -2,323 | -7,858 | -5,899 | -4,257 |